- Home
- / OliPass Corporation
OliPass Corporation
Stock Price
₩454
2024-10-04
Market Capitalization
₩1.6 B
2024-10-04
Revenue
₩756 M
FY, 2024
OliPass Corporation Summary
Company Summary
- Overview
- OliPass Corporation (previously known as CTI-Bio) is a biotech company focused on healthy aging. It is engaged in developing OliPass PNA (peptide nucleic acid) platform technology designed for artificial nucleic acid therapeutics.
- Type
- Public
- Status
- Active
- Founded
- 2006
- HQ
- Yongin-si, KR | view all locations
- Cybersecurity rating
Table of Contents
LocationsView all
2 locations detected
Yongin-si, Gyeonggi-do HQ
Korea (Republic of)
Giheung-gu
Suwon, Gyeonggi-do
Korea (Republic of)
11th Floor, 147 Gwanggyo-ro, Woncheon-dong, Yeongtong-gu
OliPass Corporation Financials
Summary Financials
- Revenue (Q2, 2025)
- ₩159.1M
- Gross profit (Q2, 2025)
- ₩460.2M
- Net income (Q2, 2025)
- (₩9.8B)
- Cash (Q2, 2025)
- ₩187.3M
- EBIT (Q2, 2025)
- (₩6.3B)
- Enterprise value
- $10.4B
Footer menu
Product
- Intelligence Suite
- Supplier Intelligence Platform
- Craft Intelligence Portal
- Craft API
- Craft for Teams
- Supplier Intelligence Platform
- Craft Alerts
- Craft N-Tier Mapping
- Craft Risk Hub
- Chrome extension
Resources
© Craft.co 2026